期刊文献+

奥美拉唑联合铝碳酸镁片治疗十二指肠球后溃疡的疗效观察 被引量:11

Clinical study of omeprazole combined with aluminum magnesium carbonate tablets in treatment of postbulbar duodenal ulcer
下载PDF
导出
摘要 目的观察奥美拉唑联合铝碳酸镁片治疗十二指肠球后溃疡的临床疗效及不良反应。方法将56例十二指肠球后溃疡患者随机分为两组,对照组28例仅采用奥美拉唑治疗;治疗组28例在对照组治疗基础上加用铝碳酸镁片,两组疗程均为4周。观察两组患者临床症状、胃镜及药物不良反应变化。结果治疗组治疗总有效率(92.9%)明显优于对照组(82.1%)(P<0.05);治疗组溃疡愈合率(82.1%)明显优于对照组(71.4%)(P<0.05);两组治疗期间均未出现明显不良反应。结论奥美拉唑联合铝碳酸镁片治疗能明显改善十二指肠球后溃疡患者的临床症状,促进溃疡愈合,且无严重不良反应。 Objective To investigate the clinical efficacy and adverse reactions of omeprazole combined with aluminum magnesium carbonate tablets in treatment of postbulbar duodenal ulcer. Methods 56 patients with postbulbar duodenal ulcer were randomly divided into two groups. The control group (n= 28) was treated with omeprazole, while the treatment group (n= 28) was treated with omeprazole combined with aluminum magnesium carbonate tablets. The treatment duration lasted four weeks. Clinical symptoms, changes of gastroscopy and adverse reactions were observed. Results The total effective rate of treatment group (92.9%) was significantly better than that of control group (82. 1%) (P〈 0.05) ; The ulcer healing rate of treatment group (82. 1%) was significantly better than that of control group (71.4%) (P〈0.05) ;There were no obvious adverse reactions happened in two groups during treatment. Conclusion Omeprazole combined with aluminum magnesium carbonate tablets in the treatment of postbulbar duodenal ulcer can significant improve the clinical symptoms, promote ulcer healing, and have no serious adverse reactions.
作者 徐鹏程
出处 《西部医学》 2012年第7期1290-1291,共2页 Medical Journal of West China
关键词 奥美拉唑 铝碳酸镁片 十二指肠球后溃疡 Omeprazole Aluminum magnesium carbonate tablets Postbulbar duodenal ulcer
  • 相关文献

参考文献5

二级参考文献17

  • 1滕晓生.奥美拉唑治疗幽门螺杆菌相关性胃溃疡的进展[J].中国临床医生杂志,2005,33(8):41-42. 被引量:11
  • 2潘邦兴,陈佳敏,杜勤,郑健.科玛诺、奥美拉唑联合治疗胃溃疡的临床疗效观察[J].浙江医学,2007,29(1):82-84. 被引量:9
  • 3Ko0p H, Kuly S, Flug M, et al. Intragastric ph and serum gastrinduring adminstration of different doses of pantoprazole inhuthy subjects. Eur J Gastroenterol Mepatol, 1996,8:915-918.
  • 4Kieser G w, Jackson R w How coldarthroscopyArthroscopy,2006,22 (4) :545-350.
  • 5Gatta L,Perm F,Figura N,et al.Antimicrobial activity of esomeprazole versus omeprazole against helicobacter pylori[J].J Antimicrob Chemother,2003,51 (2):439-442.
  • 6Tulassay Z,Kryszewski A,Dite P,et al.Qne week treatment with esomeprazlole-based triple therapy eradicates H.pylory and heals patients with duodenal ulcer disease[J].Eur J Gastroenterol Hepatol,2001,13(12):1457.
  • 7梁湛聪.消化性溃疡中西医内科治疗进展.现代消化及介入治疗,2000,5:38-38.
  • 8N.Vakil.New pharmacological agents for the treatment of gastro‐oesophageal reflux disease[J].Alimentary Pharmacology & Therapeutics.2004(10)
  • 9David J,Ott MD.Gastroesophageal reflux disease[].The Radiologic clinies of North America.1994
  • 10胡伏莲,胡品津,刘文忠,王继德,吕农华,萧树东,张万岱,成虹,谢勇.第三次全国幽门螺杆菌感染若干问题共识报告[J].胃肠病学,2008,13(1):42-46. 被引量:388

共引文献39

同被引文献61

引证文献11

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部